Posted on 8/8/17
What's Behind TG Therapeutics Inc.'s 14.4% Rally in July?
What happenedShares of TG Therapeutics Inc. (NASDAQ:TGTX) gained 14.4% in July, according to data from S&P Global Market Intelligence, despite a lack of positive announcements. It . . .
Posted on 8/7/17
MSD Animal Health to Purchase Manufacturing Facility in Krems, Austria
MSD Animal Health, known as Merck Animal Health in the United States and Canada, today announced plans to purchase a new manufacturing facility in Krems an . . .
Posted on 8/7/17
Charles River Laboratories Acquires Brains On-Line
Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Brains On-Line, a leading contract research organization
Posted on 8/7/17
MetLife Completes Spin-Off of Brighthouse Financial
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced it has completed the spin-off of Brighthouse Financial, Inc. (NASDAQ: BHF), creating two independent, publicly-traded companies. Today marks . . .
Posted on 8/7/17
Bristol-Myers Squibb: A Combined Value And Growth Story
BackgroundBristol-Myers Squibb (NYSE:BMY) was formed from a merger of two old-line pharma companies more than a quarter century ago. At the time, it was a powerhouse. . . .
Posted on 8/7/17
Celgene vs. Gilead Sciences: Who Reported Better Earnings?
Celgene Corp. (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) reported second-quarter earnings that were better than industry-watchers' forecasts, but these two giants' circumstances are very different. While Celgene . . .
Posted on 8/7/17
Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years
Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) is a staple in the portfolios of conservative long-term investors and seniors alike.For decades, J&J, as the company is more . . .
Posted on 8/7/17
John Theurer Cancer Center and MedStar Georgetown University Hospital Announce 100th Blood Stem Cell Transplant
WASHINGTON & HACKENSACK, N.J.--(BUSINESS WIRE)--MedStar Georgetown University Hospital in Washington, D.C. in collaboration with John Theurer Cancer Center, part of Hackensack Meridian Health, Hackensack University Medical . . .
Posted on 8/4/17
Citius Pharmaceuticals Prices $6,800,000 Public Offering And Listing On The Nasdaq Capital Market
CITIUS PHARMACEUTICALS, INC. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the pricing of an underwritten . . .
Posted on 8/4/17
Acuitas Health Selects Health Catalyst to Support Physicians' Transition
With physicians under increasing cost pressure from commercial health insurers and government payers, Acuitas Health, LLC today announced it will provide physician groups in New York's . . .
Posted on 8/3/17
Akers Biosciences Announces Second Quarter Trading Update
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),, a developer of rapid health information technologies, announces that sales in the second quarter ended June 30, 2017 were . . .
Posted on 8/3/17
Pfizer - Investors Remain Skeptical About Growth And The Pipeline
Pfizer (PFE) continues to post stagnant results, despite the fact that it spent vast sums on M&A in recent years. The company continues to promise the . . .
Posted on 8/3/17
Pfizer: Why The Stock May Get Interesting Again
BackgroundPfizer (PFE) delivered an in-line Q2, with consensus Street forward estimates for this year and next changing little. Rather than get into the details of a . . .
Posted on 8/3/17
A Large-Scale Acquisition Is Unlikely for Pfizer Until This Happens
Pharma titan Pfizer (NYSE:PFE) announced second-quarter earnings on Tuesday, but the drugmaker's performance was clearly a secondary issue for analysts and investors alike. Despite beating consensus . . .
Posted on 8/3/17
Wedgewood Pharmacy Receives P.E.T. Award
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy, the largest animal-health compounding pharmacy in the U.S., received the inaugural P.E.T. Award, given at the PSI Business Symposium on July 30 . . .
Posted on 8/2/17
Pfizer (PFE) Q2 2017 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE)Q2 2017 Earnings CallAugust 01, 2017 10:00 am ETExecutivesCharles E. Triano - Pfizer Inc.Ian C. Read - Pfizer Inc.Frank A. D'Amelio - Pfizer Inc.John . . .
Posted on 8/2/17
Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo
Merck & Co (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY) are engaged in a battle of sorts. The two won FDA approval for new non-small cell lung cancer . . .
Posted on 8/2/17
Spectrum Pharmacy Products Announces New Partnership with Independent Pharmacy Alliance
Spectrum Pharmacy Products, a leading global manufacturer and distributor of pharmaceutical compounding chemicals, equipment and supplies, announced its partnership with Independent Pharmacy Alliance (IPA), a trade . . .
Posted on 8/2/17
Mount Sinai Health System Partners With Contessa Health
NEW YORK & NASHVILLE, Tenn.--(BUSINESS WIRE)--The Mount Sinai Health System announced today that it has partnered with Contessa Health, an innovative health care company that manages . . .
Posted on 8/2/17
Strenuus, Now Zelis Network Analytics, Selected as a 2017 Inc. Best Workplaces Honoree
BEDMINSTER, N.J. & ATLANTA--(BUSINESS WIRE)--Zelis Healthcare, a market-leading healthcare information technology company, is pleased to announce that Strenuus, now Zelis Network Analytics, has earned a spot . . .
Posted on 7/31/17
SR Scales Introduces New, Extra-large Hospital Stretcher Scale
TONAWANDA, N.Y., July 31, 2017 (GLOBE NEWSWIRE) -- SR Instruments, a leading manufacturer of purpose-built scales for hospitals, medical facilities, and long-term care centers, announced today . . .
Posted on 7/31/17
Cantel Medical to Acquire BHT Group in Germany
CANTEL MEDICAL CORP. (NYSE:CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions
Posted on 7/31/17
Intercept Pharmaceuticals Provides Business Update
NEW YORK, July 31, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat . . .
Posted on 7/31/17
Celgene Corporation Continues to Get It Done
Celgene (NASDAQ:CELG) continues to grow revenue with its top-three drugs all experiencing sales growth of at least 20% year over year in the second quarter. The . . .
Posted on 7/31/17
3 Things You Can Expect With Pfizer's Q2 Results
There was good news and bad news for Pfizer (NYSE:PFE) the last time it reported quarterly results. In May, the big drugmaker announced earnings for the . . .

